OR WAIT null SECS
Regulatory Roundup: USP and Russia's Roszdravnadzor Sign MOU
The US Pharmacopeia (USP) and Russia’s Roszdravnadzor, the federation’s regulatory healthcare agency, signed a memorandum of understanding in April 2009 to work toward protecting and improving the quality of medicines. As part of the agreement, USP announced on June 1, 2010, that it has completed a series of eight drug quality courses at Moscow’s Scientific Center for Expertise of Medical Products. Approximately 100 Russian laboratory specialists attended the workshops.